Tidemark’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448 Sell
7
-3
-30% -$197 ﹤0.01% 818
2026
Q1
$712 Buy
10
+7
+233% +$552 ﹤0.01% 728
2025
Q4
$246 Sell
3
-15
-83% -$1.17K ﹤0.01% 637
2025
Q3
$1.35K Hold
18
﹤0.01% 618
2025
Q2
$1.33K Buy
18
+15
+500% +$1.04K ﹤0.01% 628
2025
Q1
$242 Buy
+3
New +$258 ﹤0.01% 687
2024
Q4
Sell
-3
Closed -$282 646
2024
Q3
$282 Hold
3
﹤0.01% 609
2024
Q2
$234 Hold
3
﹤0.01% 603
2024
Q1
$273 Buy
+3
New +$250 ﹤0.01% 678

Other funds holding GEHC

Tidemark's GEHC Position: Q2 2026 in Review

Tidemark reduced its GE HealthCare (GEHC) stake by 30% in Q2 2026, selling an estimated $197 and leaving 7 shares worth $448. The position accounts for ﹤0.01% of the portfolio, ranked #818.

Tidemark first reported a position in GEHC in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.35K in Q3 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Tidemark held 7 shares of GE HealthCare worth $448 as of Q2 2026.
  • Tidemark sold 3 GE HealthCare shares in Q2 2026, an estimated $197.
  • GE HealthCare made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #818 holding.
  • Tidemark first reported a position in GE HealthCare in Q1 2024 and has held it in 9 quarters since.
  • Tidemark's GE HealthCare position peaked at $1.35K in Q3 2025.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.